GridAI Technologies Corp.
$2.79
▼
-3.63%
2026-04-21 07:10:01
www.grid-ai.com
NCM: GRDX
Explore GridAI Technologies Corp. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$9.38 M
Current Price
$2.79
52W High / Low
$5.84 / $0.97
Stock P/E
—
Book Value
—
Dividend Yield
—
ROCE
-27%
ROE
-58.82%
Face Value
—
EPS
$-11.66
Exp Qtr EPS
—
Sector
Healthcare
Industry
Biotechnology
Employees
—
Beta
—
Debt / Equity
0
Current Ratio
3.03
Quick Ratio
3.03
Forward P/E
—
Price / Sales
—
Enterprise Value
—
EV / EBITDA
—
EV / Revenue
—
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Surrozen, Inc. | $32.25 | — | $362.52 M | — | -47.4% | 231.45% | $33.22 / $5.9 | $-19.21 |
| 2. | ADMA Biologics, Inc. | $10.88 | 17.68 | $2.6 B | — | 34.51% | 35.56% | $25.67 / $7.21 | $2.01 |
| 3. | Arvinas, Inc. | $10.81 | — | $703.57 M | — | -20.59% | -16.23% | $14.51 / $5.9 | $6.83 |
| 4. | Fate Therapeutics, Inc. | $1.39 | — | $158.12 M | — | -52.22% | -51.84% | $1.94 / $0.91 | $1.8 |
| 5. | Regeneron Pharmaceuticals, Inc. | $753.59 | 17.99 | $79.36 B | 0.5% | 10.23% | 14.86% | $821.11 / $476.49 | $304.65 |
| 6. | Fennec Pharmaceuticals Inc. | $6.73 | — | $232.02 M | — | -10.57% | -65.82% | $9.92 / $5.02 | $1.04 |
| 7. | Lite Strategy, Inc. | $1.19 | — | $42.54 M | 0% | -103.09% | -76.38% | $9 / $0.95 | $2.23 |
Quarterly Results
Figures shown in M / B
| Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -0.93 M | -0.64 M | -0.82 M | -1.2 M | -1.89 M |
| Net Profit | -1.15 M | -1 M | -1.26 M | -12.24 M | -2.58 M |
| EPS in Rs | -0.34 | -0.3 | -0.37 | -3.64 | -0.77 |
Profit & Loss
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -15.62 M | -15.77 M | -12.68 M | -56.7 M |
| Net Profit | -18.06 M | -15.79 M | -14.63 M | -58.54 M |
| EPS in Rs | -5.37 | -4.7 | -4.35 | -17.41 |
Balance Sheet
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Total Assets | 85.41 M | 6.88 M | 5.44 M | 11.79 M |
| Total Liabilities | 27.61 M | 3.28 M | 2.7 M | 19.61 M |
| Equity | 57.8 M | 3.6 M | 2.74 M | -7.82 M |
| Current Assets | 83.48 M | 4.96 M | 3.41 M | 9.42 M |
| Current Liabilities | 27.55 M | 3.13 M | 2.48 M | 12.3 M |
Cash Flow
Last available yearly cash flow history
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Operating CF | -9.22 M | -12.38 M | -22.34 M | -32.29 M |
| Investing CF | 0.09 M | -0.5 M | 0 M | -10.32 M |
| Financing CF | 5.58 M | 15.23 M | 15.74 M | 44.76 M |
| Free CF | -9.22 M | -12.88 M | -22.34 M | -42.61 M |
| Capex | — | -0.5 M | — | -10.32 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | — | — | — | — |
| Earnings Growth % | -14.34% | -7.97% | 75.01% | — |
| Profit Margin % | — | — | — | — |
| Operating Margin % | — | — | — | — |
| Gross Margin % | — | — | — | — |
| EBITDA Margin % | — | — | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2025-08-18 | 1:0.333333 |
| 2023-12-18 | 1:0.05 |
| 2023-01-18 | 1:0.142857 |
| 2022-08-26 | 1:0.0333333 |
| 2021-09-13 | 1:0.1 |